The activation marker CD44 was highly expressed in tumor-infiltrating CD8+ and CD4+ T cells, but CD8+ T cells in KO tumors expressed significantly lower levels of CD44 than did those in WT tumors (Supplemental Figure 7, A and B). The gene discussed is CD4; the disease is neoplasm.